Bio-MEMS eye sensor for continuous monitoring of intraocular pressure

青光眼是可预防失明的主要原因，尤其是在60岁以上人群中，青光眼是由高眼压引起的。目前监测和预防青光眼相关失明的治疗方法是通过滴眼液、激光治疗或手术来降低眼压。该项目通过确保独立性和生活质量，同时降低长期的医疗和社会成本，使我们的老龄化人口直接受益。通过将纳米技术与眼科相结合，我们将为长期、可靠的家庭眼压监测提供一种经济的解决方案。植入式眼压传感器将识别需要更多侵入性治疗的患者，而不是那些侵袭性较低的疾病，从而更好地利用医疗资源。

Glaucoma is a leading cause of preventable blindness, particularly prevalent in the 60+ population, caused by elevated intraocular pressure (IOP). Current treatment to monitor and prevent glaucoma-related blindness is by lowering IOP with eye-drops, laser therapy or surgery. This project directly benefits our aging population by ensuring independence and quality of life, whilst reducing long-term medical and social costs. By incorporating nanotechnology with ophthalmology we will provide an economic solution to long-term, reliable, home-monitoring of IOP. An implantable IOP sensor, will identify patients requiring more invasive treatment compared with those with less aggressive disease, leading to better health resource utilisation.